Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Lindsey Ashton"'
Autor:
Zitta B Harboe, Palle Valentiner-Branth, Helene Ingels, Jeppe N Rasmussen, Peter H S Andersen, Catherine C Bjerre, David Goldblatt, Lindsey Ashton, Mitch Haston, Helle B Konradsen, Lotte Lambertsen, Danish Pneumococcal Surveillance Collaborating Group
Publikováno v:
PLoS ONE, Vol 8, Iss 1, p e51460 (2013)
A seven-valent pneumococcal conjugate vaccine (PCV7) was introduced in the Danish childhood immunization program (2+1 schedule) in October 2007, followed by PCV13 starting from April 2010. The nationwide incidence of IPD among children younger than 5
Externí odkaz:
https://doaj.org/article/1ec35ee7ac7d4823afd1d9aebf3a7c41
Autor:
Nicholas P. J. Day, Auscharee Jankhot, E. Lwe, Lindsey Ashton, Paul Turner, David Goldblatt, François Nosten, Nicholas J. White, Claudia Turner, Nicola H. Green
Publikováno v:
Clinical Microbiology and Infection
Assessment of antibody responses to pneumococcal colonization in early childhood may aid our understanding of protection and inform vaccine antigen selection. Serum samples were collected from mother-infant pairs during a longitudinal pneumococcal co
Autor:
Lindsey Ashton, Sophie E. Moore, Andrew M. Prentice, Shousun C. Szu, Anna A. Richards, David Goldblatt
Publikováno v:
Vaccine
Highlights ► We investigate predictors of response to vaccination in young Gambian adults. ► We focus on both early-life and contemporary nutritional and environmental exposures. ► Pre-vaccination antibody titres were a consistent predictor of
Autor:
Nick Andrews, Elizabeth Miller, Ray Borrow, Pauline Waight, Elizabeth Sheasby, Jamie Findlow, Helen Findlow, David Goldblatt, Lindsey Ashton, Mary Matheson, Anna England
Publikováno v:
Pediatric Infectious Disease Journal. 31:616-622
Background: From 1999, in the United Kingdom, meningococcal C conjugate (MCC) vaccines from 3 manufacturers were introduced to the infant immunization schedule at 2, 3 and 4 months of age. In 2006, the schedule was refined to a 2-dose primary schedul
Publikováno v:
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Immunization of Kenyan newborns with 7-valent pneumococcal conjugate vaccine is safe and immunogenic. Compared with the Expanded Programme on Immunization schedule beginning at 6 weeks, it stimulates similar antibody concentrations at 18 weeks and in
Autor:
Milan S. Blake, R. Burton, Nathalie Durant, Kathrin U. Jansen, J. Raab, Charles E. Rose, J. Lin, L. Lee, Lindsey Ashton, Ian M. Feavers, L. Katz, Brian D. Plikaytis, Daniel S. Schmidt, David Goldblatt, Peter C. Giardina, Sandra Romero-Steiner, Philip Fernsten, Moon H. Nahm, L. Kierstead, Mustafa Akkoyunlu, George M. Carlone, Joseph M. Antonello, R. Care, F. Fievet, Jean-François Maisonneuve, Jack T. Stapleton
Publikováno v:
Clinical and Vaccine Immunology. 18:1728-1736
Lot 89SF has been the reference standard serum pool used in pneumococcal enzyme-linked immunosorbent assays (ELISAs) since 1990. In 2005, it was estimated that there remained between 2 and 5 years' supply of lot 89SF. Since lot 89SF was the reference
Autor:
David Goldblatt, Nick Andrews, Elaine Stanford, Mary Matheson, Anna England, Jo Southern, Helen Findlow, Elizabeth Miller, Ray Borrow, Elizabeth Sheasby, Lindsey Ashton, Pauline Waight
Publikováno v:
Clinical and Vaccine Immunology. 18:367-372
The coadministration of the combined meningococcal serogroup C conjugate (MCC)/ Haemophilus influenzae type b (Hib) vaccine with pneumococcal conjugate vaccine (PCV7) and measles, mumps, and rubella (MMR) vaccine at 12 months of age was investigated
Autor:
Lindsey Ashton, Nick Andrews, Elizabeth Miller, David Goldblatt, Jo Southern, Polly Burbidge, Pauline Waight, Sarah Woodgate
Publikováno v:
Pediatric Infectious Disease Journal. 29:401-405
Background: Pneumococcal conjugate vaccine (PCV) was introduced in the United Kingdom immunization schedule in September 2006. This study was conducted to establish the immunogenicity of licensed PCV (Prevenar) at a reduced, 2 priming dose schedule (
Autor:
Sarah Woodgate, Polly Burbidge, Lindsey Ashton, Richard Pebody, Jo Southern, David Goldblatt, Nick Andrews, Elizabeth Miller
Publikováno v:
Clinical Infectious Diseases. 49:1318-1325
Background Infections with pneumococci are a major cause of morbidity and mortality in the elderly population. Although 23-valent pneumococcal polysaccharide vaccine (PPV) is recommended for elderly persons, the potential benefits of conjugate vaccin
Autor:
David Goldblatt, Mahein Hussain, Nick Andrews, Lindsey Ashton, Camilla Virta, Alessia Melegaro, Richard Pebody, Robert George, Anu Soininen, John Edmunds, Nigel Gay, Helena Kayhty, Elizabeth Miller
Publikováno v:
The Journal of Infectious Diseases. 192:387-393
Background Natural immunity to Streptococcus pneumoniae is thought to be induced by exposure to S. pneumoniae or cross-reactive antigens. No longitudinal studies of carriage of and immune responses to S. pneumoniae have been conducted using sophistic